Body Positioning and Medical Therapy for Infantile Gastroesophageal Reflux Symptoms

被引:42
作者
Loots, Clara [1 ]
Kritas, Stamatiki [2 ]
van Wijk, Michiel [1 ]
McCall, Lisa [2 ]
Peeters, Laura [1 ]
Lewindon, Peter [3 ]
Bijlmer, Rob [4 ]
Haslam, Ross [4 ]
Tobin, Jacinta [5 ]
Benninga, Marc [1 ]
Davidson, Geoffrey [2 ]
Omari, Taher [2 ]
机构
[1] Emma Childrens Hosp, AMC, Amsterdam, Netherlands
[2] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia
[3] Royal Childrens Hosp, Brisbane, Qld, Australia
[4] Womens & Childrens Hlth Network, Neonatal Intens Care Unit, Adelaide, SA, Australia
[5] Univ Melbourne, North Western Acad Ctr, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
diagnosis; gastroesophageal reflux; treatment; ESOPHAGEAL SPHINCTER RELAXATION; PROTON-PUMP INHIBITORS; PREMATURE-INFANTS; CONTROLLED-TRIAL; PRETERM INFANTS; DEATH-SYNDROME; IMPEDANCE; CHILDREN; DISEASE; ACID;
D O I
10.1097/MPG.0000000000000395
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Proton-pump inhibitors (PPIs) reduce acid gastroesophageal reflux (GER) and esophageal acid exposure in infants; however, they do not reduce total GER or symptoms attributed to GER. Reflux is reduced in the left lateral position (LLP). We hypothesize that the effect of LLP in combination with acid suppression is most effective in reducing GER symptoms in infants. Methods: In this prospective sham-controlled trial, infants (0-6 months) with symptoms suggestive of gastroesophageal reflux disease were studied using 8-hour pH-impedance, cardiorespiratory and video monitoring, direct nurse observation, and a validated questionnaire. Infants demonstrating a positive GER symptom association were randomized to 1 of 4 groups; PPI + LLP, PPI + head of cot elevation (HE), antacid (AA) + LLP, or AA + BE. BE and AA were considered "sham" therapies. After 2 weeks the 8-hour studies were repeated on-therapy. Results: Fifty-one patients were included (aged 13.6 [2-26] weeks). PPI + LLP was most effective in reducing GER episodes (69 [13] to 46 [10], P<0.001) and esophageal acid exposure (median [interquartile range] 8.9% [3.1%-18.1%] to 1.1% [0%-4.4%], P=0.02). No treatment group showed improvement in crying/irritability, although vomiting was reduced in AA + LLP (from 7 [2] to 2 [0] episodes P=0.042). LLP compared with HE produced greater reduction in total GER (-21 [4] Vs 10 [4], P=0.056), regardless of acid-suppressive therapy. Acid exposure was reduced on PPI compared with AA (-6.8 [2.1] vs 0.9 [1.4]%, pH < 4, P=0.043) regardless of positional intervention. A post-hoc analysis using automated analysis software revealed a significant reduction in crying symptoms in the PPI + LLP group (99 [65-103] to 62 [32-96] episodes, P=0.018). Conclusions: "Symptomatic gastroesophageal reflux disease" implies disease causation for distressing infant symptoms. In infants with symptoms attributed to GER, LLP produced a significant reduction in total GER, but did not result in a significant improvement in symptoms other than vomiting; however, automated analysis appeared to identify infants with GER-associated crying symptoms who responded to positioning therapy. This is an important new insight for future research.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 32 条
[1]   Effect of cisapride on gastric emptying in premature infants with feed intolerance [J].
Barnett, CP ;
Omari, T ;
Davidson, GP ;
Goodchild, L ;
Lontis, R ;
Dent, J ;
Haslam, RR .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2001, 37 (06) :559-563
[2]   Proton pump inhibitor utilization patterns in infants [J].
Barron, John J. ;
Tan, Hiangkiat ;
Spalding, James ;
Bakst, Wan W. ;
Singer, Joseph .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 45 (04) :421-427
[3]   Sudden infant death syndrome and sleeping position in pre-term and low birth weight infants: an opportunity for targeted intervention [J].
Blair, PS ;
Platt, MW ;
Smith, IJ ;
Fleming, PJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 2006, 91 (02) :101-106
[4]  
Boeckxstaens GE, 1998, AM J GASTROENTEROL, V93, P1823
[5]   Effectiveness and Safety of Proton Pump Inhibitors in Infantile Gastroesophageal Reflux Disease [J].
Higginbotham, Tanner W. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) :572-576
[6]   CRITERIA FOR OBJECTIVE DEFINITION OF TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATION [J].
HOLLOWAY, RH ;
PENAGINI, R ;
IRELAND, AC .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 268 (01) :G128-G133
[7]   Interobserver and Intraobserver Variability in pH-Impedance Analysis between 10 Experts and Automated Analysis [J].
Loots, Clara M. ;
van Wijk, Michiel P. ;
Blondeau, Kathleen ;
Dalby, Kasper ;
Peeters, Laura ;
Rosen, Rachel ;
Salvatore, Silvia ;
Wenzl, Tobias G. ;
Vandenplas, Yvan ;
Benninga, Marc A. ;
Omari, Taher I. .
JOURNAL OF PEDIATRICS, 2012, 160 (03) :441-U131
[8]   Addition of pH-Impedance Monitoring to Standard pH Monitoring Increases the Yield of Symptom Association Analysis in Infants and Children with Gastroesophageal Reflux [J].
Loots, Clara M. ;
Benninga, Marc A. ;
Davidson, Geoffrey P. ;
Omari, Taher I. .
JOURNAL OF PEDIATRICS, 2009, 154 (02) :248-252
[9]   Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates:: Rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux [J].
Lopez-Alonso, Manuel ;
Moya, Maria Jose ;
Cabo, Jose Antonio ;
Ribas, Juan ;
Macias, Maria del Carmen ;
Silny, Jiry ;
Sifrim, Daniel .
PEDIATRICS, 2006, 118 (02) :E299-E308
[10]   Randomised controlled trial of cisapride in preterm infants [J].
McClure, RJ ;
Kristensen, JH ;
Grauaug, A .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1999, 80 (03) :F174-F177